Bio
Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, VCU. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. While at CAS, Kavita has worked on a wide range of topics including immuno-oncology, CRISPR therapeutics, rare diseases, and nano biosensors in Life Sciences as well as covalent inhibitors and PROTACs in Medicinal Chemistry.
Biotechnology
Could xenotransplantation solve organ transplant shortages?
With the advent of genetic editing technology, researchers are increasingly able to address immuno-compatibility issues, getting closer to making organs and tissues available for transplant from animal donors to human recipients.
药物开发
抗癌PPI抑制剂在临床试验中取得进展
小分子 PPI 抑制剂即将改善癌症治疗
新兴科学
Co-occurring concepts reveal new research directions in immuno-oncology
Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
药物开发
PROTACs revolutionize small molecule drugs
PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
Biotechnology
网络研讨会：癌症治疗探索的大数据见解
最近举行的癌症与大数据专家网络研讨会揭示了免疫肿瘤学的新兴趋势、数据挑战以及研究人员面临的机遇。
药物开发
免疫疗法和癌症的新兴趋势
在本文中揭示免疫肿瘤学出版物和研究领域的新趋势，确定未来的新机遇和挑战。